NEW DELHI:Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme…
HYDERABAD:Bharat Biotech, a global leader in vaccine development and innovation, announced today that the safety and efficacy analysis data from…
HYDERABAD:Bharat Biotech, a global leader in vaccine development and innovation, today announced that COVAXIN®, India’s first indigenous Covid-19 vaccine, has…
MUMBAI:The manufacturing, testing, release and distribution of vaccines is a complex and multifactorial process with hundreds of steps, requiring a…
NEW DELHI:The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Bharat…
NEW DELHI:Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine ''Covaxin'' it plans to sell to…
HYDERABAD:Bharat Biotech announces scale up of manufacturing capacity to produce ~ 700 million doses of COVAXIN® annually. Manufacturing scale up…
HYDERABAD:Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of…
NEW DELHI:As India launches the world’s most ambitious and biggest vaccination drive against the COVID-19, the country will encounter the…
AMBALA:Haryana Health Minister Anil Vij was on Friday administered a trial dose of potential coronavirus vaccine Covaxin here, becoming the…
This website uses cookies.